Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-337-5 | CAS number: 39186-58-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- 1) No data on mitogenic stimulation or the metaphase-arresting substance, 2) Only 100 meta phase spreads scored per concentration.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 4-bromo-2,2-diphenylbutanenitrile
- EC Number:
- 254-337-5
- EC Name:
- 4-bromo-2,2-diphenylbutanenitrile
- Cas Number:
- 39186-58-8
- Molecular formula:
- C16H14BrN
- IUPAC Name:
- 4-bromo-2,2-diphenylbutanenitrile
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): JNJ-1597622-AAA (T000625)
- Physical state: solid (powder)
- Appearance: White powder
Constituent 1
- Specific details on test material used for the study:
- Description : White crystalline solid
Purity : 100%
Label : T 625 CODE NO. 002844
Date received : 2003-12-22
Storage conditions : Room temperature in the dark
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: human
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- induced rat liver homogenate metabolising system (S9)
- Test concentrations with justification for top dose:
- - Preliminary Toxicity Test: 0, 11.72, 23.44, 46.88, 93.75, 187.5, 375, 750, 1500 and 3000 μg/mL
The results of a preliminary toxicity test were used to set the concentration range for the chromosome aberration test:
- Group 1 (4-hour without S9 with 20 hour expression time): 0, 11.72, 23.44, 46.88, 93.75, 140.63, and 187.5 μg/mL (0, 46.88, 93.75 and 140.63 μg/mL were selected for metaphase analysis)
- Group 2 (4-hour with S9 with 20 hour expression time): 0, 23.44, 46.88, 93.75, 140.63, 187.5, and 281.25 μg/mL (0, 46.88, 93.75 and 140.63 μg/mL were selected for metaphase analysis)
- Group 3 (24-hour without S9 with 0 hour expression time): 0, 5.86, 11.72, 23.44, 46.88, 70.32, and 93.75 μg/mL (0, 23.44, 46.88 and 70.32 μg/mL were selected for metaphase analysis) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: no data
- Justification for choice of solvent/vehicle: no data
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without metabolic activation; at 0.4 μg/mL for the 4(20) hour exposure and 0.2 μg/mL for the 24 hour continuous exposure (Groups 1 and 3 respectively)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with activation; at 10 µg/mL for the 4(20) hour exposure (Group 2)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- 24-hour exposure without S9-mix, 0.2 µg/mL MMC
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 hours (Groups 1 and 2); 24 hours (Group 3)
- Expression time: 20 hours (Groups 1 and 2) was provided in the study report as the expression period. However, no information was given on the time of addition of a spindle inhibitor ; 0 hours (Group 3)
- Fixation time: 24 hours (all groups)
SPINDLE INHIBITOR (cytogenetic assays): no data
STAIN (for cytogenetic assays): no data
NUMBER OF REPLICATIONS: 2 (only one of the duplicate cultures was assessed for the incidence of cells with chromosome aberrations unless there was a need to clarify an equivocal response)
NUMBER OF CELLS EVALUATED: 100 cells per evaluated culture
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes
- Rationale for test conditions:
- No data
- Evaluation criteria:
- A positive response was recorded for a particular treatment if the % cells with aberrations, excluding gaps, markedly exceeded that seen in the concurrent control, either with or without a clear dose-relationship. For modest increase in aberrations frequency a dose response relationship was generally required and appropriate statistical tests may have been applied in order to record a positive response.
- Statistics:
- No data, but statistical analysis was performed.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: In the dose range-finding experiment a precipitate of test material was observed at and above 93.75 μg/ml
RANGE-FINDING/SCREENING STUDIES: Microscopic assessment of the slides prepared from the treatment cultures showed that metaphase cells were present at up to 750 μg/ml in the pulse exposure groups and 46.88 μg/ml in the continuous exposure group. In the 4(20) hours pulse exposure groups the data show dose-related test material-induced toxicity in both exposure groups with an approximate 50% growth inhibition at 93.75 and 187.5 μg/ml in the without and with-S9 exposure groups, respectively. In 24 hour exposure group there was a steep toxicity curve and no reduction in MI was observed at 46.88 μg/ml but no metaphases at 93.75 μg/ml. Therefore, the selection of the dose range for the chromosome aberration test was based on toxicity.
COMPARISON WITH HISTORICAL CONTROL DATA: All of the vehicle control cultures had frequencies of cells with chromosome aberrations within the expected range. The positive control materials induced statistically significant increases in the frequency of cells with aberrations. It was therefore considered that the metabolic activation system was shown to be functional and the test method itself was operating as expected.
ADDITIONAL INFORMATION ON CYTOTOXICITY AND INDUCTION OF CHROMOSOME ABERRATIONS: A microscopic assessment of the slides showed that adequate scorable metaphase cells were present at up to 140.63 μg/ml in the 4(20)-hour exposure group without S9 and at up to the maximum dose level tested, 281.25 μg/ml, in the with-S9 group. In the 24-hour continuous exposure group metaphases were present at up to 93.75 μg/ml. The test material induced the ideal level of toxicity of approximately 50% mitotic inhibition at 140.63 μg/ml, in both of the 4-hour pulse exposure groups. In the 24-hour exposure group without S9 there was a steep toxicity curve with approximately 50% mitotic inhibition seen at 46.88 μg/ml. Dose selection for metaphase analysis was based on toxicity for all exposure groups. - Remarks on result:
- other: other: Group 1 and 2 (4 hour exposure groups)
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
negative
The test substance did not induce statistically significant increases in the frequency of cells with chromosome aberrations in the absence or presence of a liver enzyme metabolizing system after 4(20) hour exposures or 24 hour continuous exposure. The test substance was therefore considered to be non-clastogenic to human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.